Zobrazeno 1 - 10
of 48
pro vyhledávání: '"David W Covert"'
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 1137-1143 (2010)
Jordana K Schmier1, Edmund C Lau2, David W Covert31Exponent, Alexandria, VI, USA; 2Exponent, Menlo Park, CA, USA; 3Alcon Research Ltd, Fort Worth, TX, USAObjective: To determine treatment patterns and costs over a two-year period among new initiators
Externí odkaz:
https://doaj.org/article/0e29fc393acf4caa8c5b2c347f15d022
Autor:
Jordana K Schmier, David W Covert
Publikováno v:
Clinical Ophthalmology, Vol 2010, Iss default, Pp 437-445 (2010)
Jordana K Schmier1, David W Covert21Managing Scientist, Exponent Inc., Alexandria, VA, USA; 2Associate Director, Health Economics, Alcon Research Ltd., Ft. Worth, TX, USAObjective: To estimate first-year treatment costs among new initiators of topica
Externí odkaz:
https://doaj.org/article/e16ff5a2a1004b01bfc547753054c3fe
Publikováno v:
Clinical Ophthalmology, Vol 2009, Iss default, Pp 637-644 (2009)
Jordana K Schmier1, David W Covert2, Alan L Robin3,41Exponent Inc., Alexandria, VA, USA; 2Health Economics, Alcon Research Ltd., Fort Worth, TX, USA; 3Department of Ophthalmology, University of Maryland, Baltimore, MD, USA; 4Wilmer Eye Institute, Blo
Externí odkaz:
https://doaj.org/article/62eb13ec8ab144a9ba10979da407cdd2
Autor:
Jordana K Schmier, David W Covert
Publikováno v:
Clinical Ophthalmology, Vol 2009, Iss default, Pp 645-650 (2009)
Jordana K Schmier1, David W Covert21Exponent Inc., Alexandria, VA, USA; 2Alcon Research, Ltd., Fort Worth, TX, USABackground: There is an increasing body of evidence strongly suggesting that glaucoma medications may contribute to ocular surface disea
Externí odkaz:
https://doaj.org/article/ad2ed74c7afb4dd88f4eda916cf01714
Publikováno v:
Journal of Pharmacokinetics and Pharmacodynamics
Olopatadine is an antihistamine and mast cell stabilizer used for treating allergic conjunctivitis. Olopatadine 0.7% has been recently approved for daily dosing in the US, which supersedes the previously approved 0.2% strength. The objective of this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a6a8f11207192149bf442f361f1c843
http://europepmc.org/articles/PMC6061088
http://europepmc.org/articles/PMC6061088
Autor:
Ananth C. Viswanathan, Anmol Mullins, David W. Covert, Judit Banhazi, Paul McDwyer, Claudio Spera, Alberto Ferreira, Eibhlin Hudson
Publikováno v:
Advances in Therapy
Introduction Few studies have examined outcomes and potential complications among glaucoma patients who are prescribed topical beta-blockers. This study examined resource usage (number of GP visits and hospitalizations) and diagnoses of respiratory o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51d4cf0dd122a4dc67c51cb31b16802e
http://europepmc.org/articles/PMC5504207
http://europepmc.org/articles/PMC5504207
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Jordana K Schmier,1 David W Covert,2 Carolyn K Hulme-Lowe,1 Anmol Mullins,3 Emmanuel M Mahlis4 1Health Sciences, Exponent Inc., Alexandria, VA, 2Health Economics, 3Global Market Access, 4US Pharma Medical Affairs, Alcon Inc., Fort Worth, TX, USA Purp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a1fef0acc3ef361aad4282db4346822
http://europepmc.org/articles/PMC4801125
http://europepmc.org/articles/PMC4801125
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Jordana K Schmier,1 Carolyn K Hulme-Lowe,1 David W Covert21Exponent, Alexandria, VA, USA; 2Alcon Research Ltd., Fort Worth, TX, USAPurpose: To analyze patterns of use of adjunctive therapies among new initiators of topical prostaglandin analogs (PGAs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b08cc3299b0f08cb2563926a1affbf1
http://europepmc.org/articles/PMC4061175
http://europepmc.org/articles/PMC4061175
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Jordana K Schmier,1 Carolyn K Hulme-Lowe,1 David W Covert,2 Edmund C Lau3 1Exponent, Inc., Health Sciences, Alexandria, VA, 2Alcon Research Ltd., Fort Worth, TX, 3Exponent, Inc., Health Sciences, Menlo Park, CA, USA Background: Endophthalmitis, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449528aa9313ea1da12fc2fc58fb061e
https://www.dovepress.com/an-updated-estimate-of-costs-of-endophthalmitis-following-cataract-sur-peer-reviewed-article-OPTH
https://www.dovepress.com/an-updated-estimate-of-costs-of-endophthalmitis-following-cataract-sur-peer-reviewed-article-OPTH
Autor:
Jennifer Stone, Alan L. Robin, Susan J. Blalock, David W. Covert, Kelly W. Muir, Betsy Sleath, Asheley Cockrell Skinner
Publikováno v:
British Journal of Ophthalmology. 96:258-262
Aims The aims of this study were: (1) to examine whether the original glaucoma medication adherence and eye drop technique self-efficacy scales could be shortened for easier use in practice settings; and (2) to validate these scales against objective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1360b84921835261d8df0cb65b970d0
https://doi.org/10.1136/bjo.2010.199851
https://doi.org/10.1136/bjo.2010.199851